Effect of probiotics (Lactobacillus plantarum 299 plus Bifidobacterium Cure21) in patients with poor ileal pouch function: A randomised controlled trial

Scandinavian Journal of Gastroenterology

Volumn 51, Issue 9, 2016, Pages 1087-1092

  Bengtsson, J ^a   Adlerberth, I ^b   Ostblom A ^b   Saksena, P ^a   Oresland T ^c   Borjesson L ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

Biomarkers; colitis ulcerative; dysbiosis; pouchitis; probiotics; proctocolectomy restorative

Indexed keywords

CALGRANULIN; EOSINOPHIL CATIONIC PROTEIN; LACTOFERRIN; MYELOPEROXIDASE; PLACEBO; PROBIOTIC AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BIFIDOBACTERIUM INFANTIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY SCORE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GASTROINTESTINAL BIOPSY; GASTROSCOPE; HUMAN; HUMAN TISSUE; ILEITIS; ILEUM POUCH; INTESTINE FUNCTION; INTESTINE FUNCTION DISORDER; LACTOBACILLUS PLANTARUM; MALE; NAUSEA; PARALLEL DESIGN; PRIORITY JOURNAL; PROCTOCOLECTOMY; RANDOMIZED CONTROLLED TRIAL; BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS; CHEMISTRY; COLITIS, ULCERATIVE; COLOSTOMY BAG; ENDOSCOPY; FECES; MIDDLE AGED; NORWAY; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; POUCHITIS; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; BIFIDOBACTERIUM LONGUM SUBSPECIES INFANTIS; BIOMARKERS; COLITIS, ULCERATIVE; COLONIC POUCHES; DOUBLE-BLIND METHOD; ENDOSCOPY; FECES; FEMALE; HUMANS; LACTOBACILLUS PLANTARUM; MALE; MIDDLE AGED; NORWAY; POSTOPERATIVE COMPLICATIONS; POUCHITIS; PROBIOTICS; PROCTOCOLECTOMY, RESTORATIVE; SEVERITY OF ILLNESS INDEX;

EID: 84965047504     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2016.1161067     Document Type: Article

References (27)

1. I.Berndtsson, E.Lindholm, T.Oresland, et al. Long-term outcome after ileal pouch-anal anastomosis: function and health-related quality of life. Dis Colon Rectum. 2007;50:1545–1552.
2. D.S.Pardi, G.D'Haens, B.Shen, et al. Clinical guidelines for the management of pouchitis. Inflamm Bowel Dis. 2009;15:1424–1431.
3. U.A.Heuschen, F.Autschbach, E.H.Allemeyer, et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum. 2001;44:487–499.
4. M.W.Johnson, G.B.Rogers, K.D.Bruce, et al. Bacterial community diversity in cultures derived from healthy and inflamed ileal pouches after restorative proctocolectomy. Inflamm Bowel Dis. 2009;15:1803–1811.
5. P.Gionchetti, F.Rizzello, U.Helwig, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology. 2003;124:1202–1209.
6. P.Gionchetti, F.Rizzello, A.Venturi, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000;119:305–309.
7. T.Mimura, F.Rizzello, U.Helwig, et al. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut. 2004;53:108–114.
8. L.O'Mahony, J.McCarthy, P.Kelly, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128:541–551.
9. P.J.Whorwell, L.Altringer, J.Morel, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101:1581–1590.
10. A.C.Ford, E.M.Quigley, B.E.Lacy, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. Am J Gastroenterol. 2014;109:1547–1561.
11. C.N.Jacobsen, V.Rosenfeldt Nielsen, A.E.Hayford, et al. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol. 1999;65:4949–4956.
12. Y.Mao, S.Nobaek, D.Adawi, et al. Comparison of the effects of different strains of Lactobacillusin reducing bacterial translocation on methotrexate-induced enterocolitis in rats. Digest Surg. 1997;14:284–291.
13. S.Pathmakanthan, C.K.Li, J.Cowie, et al. Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. J Gastroenterol Hepatol. 2004;19:166–173.
14. N.Rayes, S.Hansen, D.Seehofer, et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition. 2002;18:609–615.
15. T.Oresland, S.Fasth, S.Nordgren, et al. The clinical and functional outcome after restorative proctocolectomy. A prospective study in 100 patients. Int J Colorectal Dis. 1989;4:50–56.
16. W.J.Sandborn, W.J.Tremaine, K.P.Batts, et al. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc. 1994;69:409–415.
17. R.L.Moskowitz, N.A.Shepherd, R.J.Nicholls An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis. 1986;1:167–174.
18. P.Gionchetti, F.Rizzello, C.Morselli, et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum. 2007;50:2075–2082. discussion 2082–2084.
19. M.Persborn, J.Gerritsen, C.Wallon, et al. The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment Pharmacol Ther. 2013;38:772–783.
20. M.A.Parsi, B.Shen, J.P.Achkar, et al. Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. Gastroenterology. 2004;126:1280–1286.
21. J.P.Gisbert, F.Bermejo, J.L.Perez-Calle, et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis. 2009;15:1190–1198.
22. U.A.Heuschen, E.H.Allemeyer, U.Hinz, et al. Diagnosing pouchitis: comparative validation of two scoring systems in routine follow-up. Dis Colon Rectum. 2002;45:776–786. discussion 786–788.
23. B.Shen, J.P.Achkar, J.T.Connor, et al. Modified pouchitis disease activity index: a simplified approach to the diagnosis of pouchitis. Dis Colon Rectum. 2003;46:748–753.
24. B.Shen, J.P.Achkar, B.A.Lashner, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol. 2002;97:972–977.
25. M.W.Johnson, S.Maestranzi, A.M.Duffy, et al. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. Eur J Gastroenterol Hepatol. 2008;20:174–179.
26. P.Thomas, H.Rihani, A.Roseth, et al. Assessment of ileal pouch inflammation by single-stool calprotectin assay. Dis Colon Rectum. 2000;43:214–220.
27. O.Ben-Bassat, A.D.Tyler, W.Xu, et al. Ileal pouch symptoms do not correlate with inflammation of the pouch. Clin Gastroenterol Hepatol. 2014;12:831–837e2.